Clinical Trials · NCT00926380
Denosumab, Teriparatide or Both for the Treatment of Postmenopausal Osteoporosis
- Phase
- Phase 2
- Recruitment status
- Completed
- Sponsor
- Massachusetts General Hospital
- Enrollment
- 94
- Start date
- Jun 2009
- Locations
- 1 site, United States
- Primary endpoint
- Change in Spine Bone Density From Baseline to 2 Years